Today the FDA has granted accelerated approval to Pfizer's HIV medicine Selzentry (or maraviroc). Hill & Knowlton has been assisting Pfizer with the drug, and it could be the first in a number of new HIV drugs to hit the market in the near future. You can see our past coverage here.